Groundbreaking Alzheimer’s Disease research at the Blanchette Rockefeller Neurosciences Institute
Outlook show about the Blanchette Rockefeller Neurosciences Institute on the campus of West Virginia University. Clinical trials will begin this summer on a drug the Institute has shown to have great potential as a treatment for Alzheimer’s disease.
Related posts:
- Learning to Speak Alzheimer’s: A Groundbreaking Approach for Everyone Dealing with the Disease
- Auburn University Alzheimer’s Disease Research
- TGen & Alzheimer’s Disease Research
- Dr. Todd Golde on Recent Alzheimer’s Disease Research (1)
- University of Maryland Research: Nicotine May Play Key Role in Promising Alzheimer’s Therapy
Their focus on protein kinase C is excellent. This is a much earlier step in the Alzheimer’s disease cascade than beta-amyloid accumulation and plaque. Excellent work. But the drug-mediated blocking of PKC inhibition will also have to block concomitant inhibition of beta-tubulin, creatine kinase, and several phosphatases before it will be a concerted or comprehensive solution to AD. Good luck BRNI!